Market News AIOpen the app

TLX stock news · Telix Pharmaceuticals Limited

Stories about Telix Pharmaceuticals Limited (TLX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TLX

Follow Telix Pharmaceuticals Limited (TLX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TLX
Free on the App Store and Google Play, or on the web.
  1. Sep 21, 2026, 11:15 AM ET · Deal

    Telix is spending $1.65 billion to merge with ITM and become a top player in radiopharmaceuticals.

    Neutral

    Telix agreed to buy ITM for $1.65 billion, adding revenue and manufacturing scale; regulatory and dilution risks cancel those gains, so the company reads neutral today.

  2. Sep 21, 2026, 8:10 AM ET · Market

    Shares of Novo Nordisk, Telix Pharmaceuticals, and other major companies dropped before the market opened on Monday.

    Neutral

    Telix signed a strategic agreement to lead a merger, which is positive, but its shares fell 7.9% pre-market, leaving mixed signals.